Tags

Type your tag names separated by a space and hit enter

Sugar-sweetened beverages consumption is associated with abdominal obesity risk in diabetic patients.
Diabetes Metab Syndr. 2017 Dec; 11 Suppl 2:S675-S678.DM

Abstract

AIM

Sugar sweetened beverages (SSBs) are any beverages containing added-sugar and supposed to increase body lipogenesis and fat accumulation in healthy subjects. This study was performed to assess the possible association between SSBs consumption and obesity in type 2 diabetes (T2DM) patients.

METHODS

T2DM adults with no insulin treatment entered the study. Abdominal obesity and general adiposity were determined using waist circumference (WC) and body mass index (BMI), respectively. SSBs intake was extracted from a validated food frequency questionnaire.

RESULTS

Mean SSBs intake was 0.6 serving/d (145.6mL/d). There was no considerable association between SSBs intake and gender. About 46% of patients consumed at least one serving of SSBs per week. SSBs consumption was correlated neither to WC nor to BMI. After adjustment for confounding factors, abdominal obesity was associated with drinking SSBs ≥1 serving/week (OR=4.93, 95% CI: 1.35-18.03), and SSB ≥3 serving/week (OR=5.07, 95% CI: 1.22-21.15) compared to those consumed <1 serving/week. This association was not found for general obesity (OR=0.88, 95% CI: 0.60-1.23). Ex-smokers had higher SSBs intake compared to those never smoked (OR=3.94, 95% CI=1.06-14.71). Energy intake and macronutrients were similar in both SSBs sub-groups. Mean daily energy supplied by SSBs was 120kcal in participants having ≥1 serving of SSBs/week and 2.7kcal in <1 serving SSBs/week (OR=1.14, 95% CI: 1.09-1.20). Lower SSBs drinkers had 17% higher fiber intake (OR=0.83, 95% CI=0.73-0.96).

CONCLUSION

SSBs intake might increase abdominal obesity in diabetic population and therefore should be considered in diabetes control procedure.

Authors+Show Affiliations

Department of Nutrition, Faculty of Autonomous Campus (Arvand International Unit), Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Electronic address: Raziehanari85@yahoo.com.Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Nutrition, Faculty of Paramedicine, Health Research Institute, Nutrition and Metabolic Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Electronic address: r_amani@mail.mui.ac.ir.Department of Nutrition, Faculty of Paramedicine, Health Research Institute, Nutrition and Metabolic Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Electronic address: m_veissi@yahoo.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28487104

Citation

Anari, Razieh, et al. "Sugar-sweetened Beverages Consumption Is Associated With Abdominal Obesity Risk in Diabetic Patients." Diabetes & Metabolic Syndrome, vol. 11 Suppl 2, 2017, pp. S675-S678.
Anari R, Amani R, Veissi M. Sugar-sweetened beverages consumption is associated with abdominal obesity risk in diabetic patients. Diabetes Metab Syndr. 2017;11 Suppl 2:S675-S678.
Anari, R., Amani, R., & Veissi, M. (2017). Sugar-sweetened beverages consumption is associated with abdominal obesity risk in diabetic patients. Diabetes & Metabolic Syndrome, 11 Suppl 2, S675-S678. https://doi.org/10.1016/j.dsx.2017.04.024
Anari R, Amani R, Veissi M. Sugar-sweetened Beverages Consumption Is Associated With Abdominal Obesity Risk in Diabetic Patients. Diabetes Metab Syndr. 2017;11 Suppl 2:S675-S678. PubMed PMID: 28487104.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sugar-sweetened beverages consumption is associated with abdominal obesity risk in diabetic patients. AU - Anari,Razieh, AU - Amani,Reza, AU - Veissi,Masoud, Y1 - 2017/04/28/ PY - 2017/04/04/received PY - 2017/04/27/accepted PY - 2017/5/11/pubmed PY - 2018/8/1/medline PY - 2017/5/11/entrez KW - Abdominal obesity KW - Diabetes KW - General obesity KW - Smoking KW - Sugar-sweetened beverages SP - S675 EP - S678 JF - Diabetes & metabolic syndrome JO - Diabetes Metab Syndr VL - 11 Suppl 2 N2 - AIM: Sugar sweetened beverages (SSBs) are any beverages containing added-sugar and supposed to increase body lipogenesis and fat accumulation in healthy subjects. This study was performed to assess the possible association between SSBs consumption and obesity in type 2 diabetes (T2DM) patients. METHODS: T2DM adults with no insulin treatment entered the study. Abdominal obesity and general adiposity were determined using waist circumference (WC) and body mass index (BMI), respectively. SSBs intake was extracted from a validated food frequency questionnaire. RESULTS: Mean SSBs intake was 0.6 serving/d (145.6mL/d). There was no considerable association between SSBs intake and gender. About 46% of patients consumed at least one serving of SSBs per week. SSBs consumption was correlated neither to WC nor to BMI. After adjustment for confounding factors, abdominal obesity was associated with drinking SSBs ≥1 serving/week (OR=4.93, 95% CI: 1.35-18.03), and SSB ≥3 serving/week (OR=5.07, 95% CI: 1.22-21.15) compared to those consumed <1 serving/week. This association was not found for general obesity (OR=0.88, 95% CI: 0.60-1.23). Ex-smokers had higher SSBs intake compared to those never smoked (OR=3.94, 95% CI=1.06-14.71). Energy intake and macronutrients were similar in both SSBs sub-groups. Mean daily energy supplied by SSBs was 120kcal in participants having ≥1 serving of SSBs/week and 2.7kcal in <1 serving SSBs/week (OR=1.14, 95% CI: 1.09-1.20). Lower SSBs drinkers had 17% higher fiber intake (OR=0.83, 95% CI=0.73-0.96). CONCLUSION: SSBs intake might increase abdominal obesity in diabetic population and therefore should be considered in diabetes control procedure. SN - 1878-0334 UR - https://www.unboundmedicine.com/medline/citation/28487104/Sugar_sweetened_beverages_consumption_is_associated_with_abdominal_obesity_risk_in_diabetic_patients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1871-4021(17)30098-X DB - PRIME DP - Unbound Medicine ER -